Table 7.
The comprison of independent testing.
| Method | Phosphorylated residue | Pre (%) | Sn (%) | Sp (%) | Acc (%) |
|---|---|---|---|---|---|
| Single HMM | S | 52.6% | 50.6% | 77.2% | 68.3% |
| T | 50.0% | 20.9% | 89.5% | 66.6% | |
| Y | 36.3% | 28.5% | 75.0% | 59.5% | |
| MDD-clustered HMMs | S | 74.2% | 81.4% | 71.6% | 76.5% |
| T | 71.8% | 77.1% | 69.7% | 73.4% | |
| Y | 72.8% | 83.7% | 68.7% | 76.2% | |
| PhosPhAt 3.0 | S | 55.5% | 61.9% | 50.6% | 56.2% |
| T | 55.0% | 57.1% | 53.3% | 55.2% | |
| Y | 4.0% | 14.2% | 78.5% | 46.4% | |
| NetPhos 2.0 | S | 58.6% | 71.6% | 49.3% | 60.5% |
| T | 47.5% | 36.1% | 59.6% | 47.8% | |
| Y | 44.4% | 28.5% | 64.2% | 46.4% | |
| DisPhos 1.3 | S | 66.8% | 60.6% | 69.3% | 65.0% |
| T | 47.5% | 36.1% | 61.2% | 48.6% | |
| Y | 57.1% | 47.5% | 64.2% | 55.8% | |